• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Focus areas
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Focus areas
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesFocus areasTry Devex Pro
    • News
    • COVID-19

    COVID-19 vaccine boosters may have 'huge' impacts on global supply

    Pfizer plans to seek U.S. authorization for a booster shot of its COVID-19 vaccine. If successful, the move could limit global access to doses, according to the World Health Organization.

    By Sara Jerving // 29 July 2021

    Related Stories

    Can Africa’s drug regulators be both fast and trusted?
    Can Africa’s drug regulators be both fast and trusted?
    Climate change mandates more innovation in yellow fever vaccines
    Climate change mandates more innovation in yellow fever vaccines
    Devex CheckUp: A chaotic week at the US CDC
    Devex CheckUp: A chaotic week at the US CDC
    Devex CheckUp: Innovative global health financing for tough times
    Devex CheckUp: Innovative global health financing for tough times
    A doctor holds a syringe containing Pfizer’s COVID-19 vaccine in Washington. Photo by: Joshua Roberts / IMF Photo / CC BY-NC-ND

    If wealthy nations — currently flush with COVID-19 vaccines — decide to give their populations booster shots, it could have “huge implications” for the availability of doses globally, a World Health Organization official said during a press conference Thursday.

    Sign up for Devex CheckUp
    The must-read weekly newsletter for exclusive global health news and insider insights.

    The statement by Africa Regional Director Matshidiso Moeti came a day after Pfizer said a third dose of its vaccine could improve immunity. While receiving two doses still provides strong, sustained protection against serious disease, effectiveness decreases over six months. The company said it plans to seek U.S. approval for a booster shot.

    Why this matters: Many wealthy countries have hoarded large supplies of vaccine doses, including by reserving them through prepayments with manufacturers. This has limited availability for low-income countries that, even with access to financing, have struggled to purchase doses.

    Fewer than 2% of the people on the African continent are fully vaccinated.

    Now that wealthy countries have vaccinated large portions of their populations, they are starting to donate doses. U.S. President Joe Biden announced last month that his government would give 500 million Pfizer doses to low- and lower-middle-income countries.

    But booster shots could change this, according to Moeti.

    “Our concern is [that] decisions to provide a third dose might influence the availability of vaccines for our countries, which are already going through a very difficult situation,” she said.

    More doses needed: The African Union, which aims to vaccinate 60% of the continent’s population, also anticipates needing more doses than initially projected, as the delta variant has increased the coronavirus’s rate of reproduction.

    “We may need more vaccines than we initially stated,” said John Nkengasong, director at the Africa Centres for Disease Control and Prevention.

    • Global Health
    • Private Sector
    • Trade & Policy
    • WHO
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Sara Jerving

      Sara Jervingsarajerving

      Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.

    Search for articles

    Related Stories

    Global healthRelated Stories - Can Africa’s drug regulators be both fast and trusted?

    Can Africa’s drug regulators be both fast and trusted?

    Sponsored by SanofiRelated Stories - Climate change mandates more innovation in yellow fever vaccines

    Climate change mandates more innovation in yellow fever vaccines

    Devex CheckUpRelated Stories - Devex CheckUp: A chaotic week at the US CDC

    Devex CheckUp: A chaotic week at the US CDC

    Devex CheckUpRelated Stories - Devex CheckUp: Innovative global health financing for tough times

    Devex CheckUp: Innovative global health financing for tough times

    Most Read

    • 1
      Why NTDs are a prime investment for philanthropy
    • 2
      When business moves faster than politics
    • 3
      Why are 3.4 billion people still offline?
    • 4
      Climate change mandates more innovation in yellow fever vaccines
    • 5
      Why a new partnership model is key to future of development finance
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2026 Devex|User Agreement|Privacy Statement